Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Travatrelvir - Traws Pharma

Next Previous
Drug Profile

Travatrelvir - Traws Pharma

Alternative Names: 83-0060; MPro; Ratutrelvir; Ratutrelvir - Traws Pharma; TRX 01

Latest Information Update: 29 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Trawsfynydd Therapeutics
  • Developer Traws Pharma
  • Class Antivirals; Small molecules
  • Mechanism of Action Coronavirus 3C-like proteinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I COVID 2019 infections

Most Recent Events

  • 15 May 2025 Traws Pharma announces intention to submit a briefing package to regulatory authorities for COVID-2019 infections in the quarter two of 2025
  • 31 Mar 2025 Traws Pharma plans a pre-IND meeting to engage with the US FDA to understand long COVID endpoints, in second quarter of 2025
  • 25 Mar 2025 Pharmacokinetics data from a phase-I trial in COVID-19 infections released by Traws Pharma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top